P2-317: Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC). A phase II study of the Lung Cancer Galician Group

Authors :: G. Huidobro
Elen Álvarez
José Luis Fírvida
J. R. Mel
M. Salgado
J. Casal
Martín Lázaro
Luis León
Sergio Vazquez-Estevez
Eva Perez
Source :: Journal of Thoracic Oncology. 2:S699
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Second line treatment
business.industry
non-small cell lung cancer (NSCLC)
Phases of clinical research
medicine.disease
chemistry.chemical_compound
Paclitaxel
chemistry
Internal medicine
medicine
Lung cancer
business

Tools